E-drug: Re: New leadership in WHO (5)
----------------------------------------------------------
I think the comment by George Oswald and Leo's comments about the
appointment of Michael Scholtz are fair. We should wait and see but what
indicators will we use to assess his performance? What do we expect him to
do? What realistic changes can we expect within 6 months?
We should remember that Michael Scholtz is responsible for both DAP and DMP
as well as health technology.
I would be interested in suggestions.
Richard Laing
Richard Laing M.B. Ch.B. M.Sc. M.D. Tel 1-617-414-1444
Associate Professor, Fax 1-617-638-4476
Department of International Health,
Boston University School of Public Health,
715 Albany Street, T4W
Boston MA 02118 USA
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.